A Reactive Prodrug Ink Formulation Strategy for Inkjet 3D Printing of Controlled Release Dosage Forms and Implants (2020)
Attributed to:
Formulation for 3D printing: Creating a plug and play platform for a disruptive UK industry
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/adtp.201900187
Publication URI: http://dx.doi.org/10.1002/adtp.201900187
Type: Journal Article/Review
Parent Publication: Advanced Therapeutics
Issue: 6